Non-pharmacologic strategies superior to drugs for poorly understood rheumatic pain healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
(CTN NEWS) - On Tuesday, the Director of the U.S. Centers for Disease Control and Prevention gave their approval for the widespread utilization of newly
Axcella Therapeutics (Nasdaq: AXLA) continues to gain traction the following week after their astonishing announcement, gaining over 40% at peak trading hours on August 7th, 2023. Their patent issuance represents a significant achievement, solidifying the company's global intellectual property position, here's a quick overview of the release. Quick Overview: The team at Axcella